- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04055597
Effects of Upper Extremity Rehabilitation Robot and Transcranial Direct Current Stimulation Among Patients With Stroke
August 12, 2019 updated by: Joon-Ho Shin, National Rehabilitation Center, Seoul, Korea
Effects of Upper Extremity Rehabilitation Robot and Transcranial Direct Current Stimulation on Upper Extremity Function Among Subjects With Tremor After Cerebellar and Brainstem Stroke
Effects of upper extremity rehabilitation robot and transcranial direct current stimulation on upper extremity function among subjects with tremor after stroke
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 142884
- Recruiting
- National Rehabilitation Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Stroke with cerebellar hemorrhage or infarction
- ataxia or tremor on upper extremities secondary to stroke
- Cognitively intact enough to understand and follow the instructions from the investigator
Exclusion Criteria:
- History of surgery of affected upper limb
- Fracture of affected upper limb
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Robot and tDCS on-line
Combined transcranial direct current stimulation(tDCS) on-line and upper extremity rehabilitation robot
|
Combined transcranial direct current stimulation(tDCS) on-line and upper extremity rehabilitation robot for 5 times a week for 4 weeks
|
Sham Comparator: Robot and sham tDCS
Combined sham tDCS and upper extremity rehabilitation robot
|
Combined sham tDCS and upper extremity rehabilitation robot for 5 times a week for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Scale for the assessment and rating of ataxia
Time Frame: Change of Scale for the assessment and rating of ataxia at 4 weeks after baseline compared to baseline
|
Change of Scale for the assessment and rating of ataxia
|
Change of Scale for the assessment and rating of ataxia at 4 weeks after baseline compared to baseline
|
Change of Functional ataxia rating scale - upper limb
Time Frame: Change of the Functional ataxia rating scale - upper limb, at 4 weeks after baseline compared to baseline
|
Change of Functional ataxia rating scale - upper limb
|
Change of the Functional ataxia rating scale - upper limb, at 4 weeks after baseline compared to baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fugl-Meyer Assessment - upper extremity
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Fugl-Meyer Assessment - upper extremity
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Composite cerebellar functional severity score
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Composite cerebellar functional severity score (Nine hole peg test + click test)
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Jerk during reaching and finger pointing
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Kinematic data during reaching and finger pointing using Trakstar
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Smoothness during reaching and finger pointing
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Kinematic data during reaching and finger pointing using Trakstar
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Behavioral activation system/behavioral inhibition system scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
In terms of motivation
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Beck's depression index
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Beck's depression index
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Stroke rehabilitation motivation scale
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Stroke rehabilitation motivation scale
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Intrinsic motivation inventory
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Intrinsic motivation inventory
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Numeric rating scale for upper extremity pain
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Question about the upper extremity pain (0-10; higher is better)
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Functional reaching test
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Functional reaching test
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
modified Barthel index
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
modified Barthel index
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
% maximal voluntary contraction from upper extremity muscles during reaching task
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
data from surface electromyography from upper extremity muscles during reaching task
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Kinematic data during scale for the assessment and rating of ataxia
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Kinematic data during scale for the assessment and rating of ataxia
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Scale for the assessment and rating of ataxia
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Scale for the assessment and rating of ataxia
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Functional ataxia rating scale - upper limb
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Functional ataxia rating scale - upper limb, kinematic data during scale for the assessment
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Kinematic data during scale during the Functional ataxia rating scale - upper limb
Time Frame: baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Kinematic data during scale during the Functional ataxia rating scale - upper limb
|
baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2017
Primary Completion (Anticipated)
December 31, 2019
Study Completion (Anticipated)
December 31, 2019
Study Registration Dates
First Submitted
March 1, 2018
First Submitted That Met QC Criteria
August 12, 2019
First Posted (Actual)
August 14, 2019
Study Record Updates
Last Update Posted (Actual)
August 14, 2019
Last Update Submitted That Met QC Criteria
August 12, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NRC-2017-01-004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on Robot and tDCS on-line
-
National Rehabilitation Center, Seoul, KoreaUnknown
-
National Rehabilitation Center, Seoul, KoreaUnknown
-
Auxilium Vitae VolterraCompleted
-
Chinese University of Hong KongRecruiting
-
University of CalgaryUnknownHemiplegic Cerebral Palsy | Perinatal StrokeCanada
-
Universidade Federal de PernambucoUnknown
-
University Hospital of FerraraCompleted
-
Hacettepe UniversityInteract Medical Technologies Inc.Not yet recruiting
-
University Hospital, MontpellierMinistry of Health, FranceCompletedCardiovascular DiseaseFrance
-
First Affiliated Hospital of Zhejiang UniversityRecruiting